Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immuneering Corporation June 13, 2025100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2025 | Immuneering Corporation | Open-market purchase | +2,500 | $3.60 | $9,000 |
| Jul 2, 2025 | Immuneering Corporation | Open-market purchase | +3,000 | $3.62 | $10,860 |
| May 9, 2024 | Zentalis Pharmaceuticals Inc. | Open-market sale | −3,356 | $12.62 | $42,353 |
| Feb 1, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +337,500 | — | — |
| May 8, 2023 | Zentalis Pharmaceuticals Inc. | Grant or award | +39,732 | — | — |
Questions about Diana Hausman
What boards is Diana Hausman on?
Diana Hausman sits on the boards of Immuneering Corporation and Zentalis Pharmaceuticals Inc.
How long has Diana Hausman served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.